Protein predicts Gleevec resistance in gastrointestinal tumors

User rating: not rated yet

Excess amounts of a protein called IGF-1R in patients with gastrointestinal stromal tumors (GISTs) could indicate that the patient would be less responsive to the drug imatinib mesylate (known as Gleevec), according to Andrew K. Godwin, Ph.D., a researcher at the Fox Chase Cancer Center in Philadelphia.


Full story »

All News summaries from Medicine & Health news
All News summaries for May 16, 2008

Booming business helps patients navigate medicine

14 minutes ago | User rating: not rated yet
(AP) -- After three surgeries, Judy Sherer still had chronic pain in her left shoulder. She'd lost faith in her doctors, and in despair tried a new health benefit offered by her employer.

Researchers identify gene responsible for rare childhood disease

22 minutes ago | User rating: not rated yet
The chromosomal abnormality that causes a rare, but often fatal, disorder that affects infants has been identified by researchers at the University of California, San Diego School of Medicine, who happened to treat two young ...

Genetic mutation identified for eye complaint

1 hour ago | User rating: not rated yet
An international research collaboration including research teams from the Children's Hospital in Boston (USA), King's College London and the Peninsula Medical School, has identified a gene that, when mutated, causes Duane ...

US fentanyl deaths topped 1,000 over 2 years

1 hour ago | User rating: not rated yet
(AP) -- More than 1,000 people died over two years from an illegal version of the painkiller fentanyl, the government reported Thursday in its first national tally of those deaths.

Officials: Search for HIV vaccine needs overhaul

1 hour ago | User rating: not rated yet
(AP) -- Scientists will have to take "enormous intellectual leaps" to develop an AIDS vaccine in the coming years, say researchers clearly frustrated by the failure of a once-promising shot.